170 related articles for article (PubMed ID: 16317298)
21. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer.
Takatori K; Terashima K; Yoshida R; Horai A; Satake S; Ose T; Kitajima N; Kinoshita Y; Demizu Y; Fuwa N
J Gastroenterol; 2014 Jun; 49(6):1074-80. PubMed ID: 23846547
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine-induced pulmonary toxicity.
Chi DC; Brogan F; Turenne I; Zelonis S; Schwartz L; Saif MW
Anticancer Res; 2012 Sep; 32(9):4147-9. PubMed ID: 22993376
[TBL] [Abstract][Full Text] [Related]
23. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
24. Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.
Huang J; Robertson JM; Ye H; Margolis J; Nadeau L; Yan D
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1120-5. PubMed ID: 22099048
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma.
Sherman WH; Chu K; Chabot J; Allendorf J; Schrope BA; Hecht E; Jin B; Leung D; Remotti H; Addeo G; Postolov I; Tsai W; Fine RL
Cancer; 2015 Mar; 121(5):673-80. PubMed ID: 25492104
[TBL] [Abstract][Full Text] [Related]
26. Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer.
Maemura K; Shinchi H; Noma H; Mataki Y; Kurahara H; Maeda S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
Anticancer Res; 2008; 28(4C):2369-72. PubMed ID: 18751420
[TBL] [Abstract][Full Text] [Related]
27. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
Wolff RA; Evans DB; Gravel DM; Lenzi R; Pisters PW; Lee JE; Janjan NA; Charnsangavej C; Abbruzzese JL
Clin Cancer Res; 2001 Aug; 7(8):2246-53. PubMed ID: 11489798
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
[TBL] [Abstract][Full Text] [Related]
29. [A case of interstitial lung disease associated with gemcitabine treatment in a patient with locally advanced pancreatic cancer following proton beam radiotherapy].
Tanaka M; Matsumoto I; Shinzeki M; Toyama H; Asari S; Goto T; Shirakawa S; Yamashita H; Sawa H; Ueno K; Takahashi M; Tsuchida S; Kido M; Ajiki T; Fukumoto T; Ku Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2158-60. PubMed ID: 23268009
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
Schneider BJ; Ben-Josef E; McGinn CJ; Chang AE; Colletti LM; Normolle DP; Hejna GF; Lawrence TS; Zalupski MM
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1325-30. PubMed ID: 15993549
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature.
Obeid KM; Venugopal AA
Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869
[TBL] [Abstract][Full Text] [Related]
32. Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.
Schilsky RL; Bertucci D; Vogelzang NJ; Kindler HL; Ratain MJ
J Clin Oncol; 2002 Jan; 20(2):582-7. PubMed ID: 11786589
[TBL] [Abstract][Full Text] [Related]
33. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
[TBL] [Abstract][Full Text] [Related]
34. [Two cases of radiation myositis probably induced by recall phenomenon].
Miura G; Matsumoto T; Tanaka N; Emoto T; Kawamura T; Matsunaga N
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):420-2. PubMed ID: 14587415
[TBL] [Abstract][Full Text] [Related]
35. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Van Laethem JL; Hammel P; Mornex F; Azria D; Van Tienhoven G; Vergauwe P; Peeters M; Polus M; Praet M; Mauer M; Collette L; Budach V; Lutz M; Van Cutsem E; Haustermans K
J Clin Oncol; 2010 Oct; 28(29):4450-6. PubMed ID: 20837948
[TBL] [Abstract][Full Text] [Related]
37. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
38. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
Tsukagoshi S
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.
Epelbaum R; Rosenblatt E; Nasrallah S; Faraggi D; Gaitini D; Mizrahi S; Kuten A
J Surg Oncol; 2002 Nov; 81(3):138-43. PubMed ID: 12407726
[TBL] [Abstract][Full Text] [Related]
40. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.
Davis JL; Pandalai P; Ripley RT; Langan RC; Steinberg SM; Walker M; Toomey MA; Levy E; Avital I
Trials; 2011 May; 12():129. PubMed ID: 21595953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
